Published in PLoS One on January 08, 2016
Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. PLoS One (2015) 1.44
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
The substitutability of reinforcers. J Exp Anal Behav (1993) 3.39
Resting state functional connectivity of the striatum in Parkinson's disease. Brain (2012) 2.53
Discounting of monetary and directly consumable rewards. Psychol Sci (2007) 2.39
Differential effects of amount on temporal and probability discounting of gains and losses. Mem Cognit (2006) 2.24
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10
The impact of litigation on neurologic research. Neurology (2006) 2.03
The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2007) 1.97
Is discounting impulsive?. Evidence from temporal and probability discounting in gambling and non-gambling college students. Behav Processes (2003) 1.97
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol (2006) 1.94
Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol (2012) 1.82
Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care (2007) 1.82
Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes (2013) 1.78
Delay discounting of cocaine by rhesus monkeys. Exp Clin Psychopharmacol (2007) 1.74
Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes (2008) 1.65
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci U S A (2007) 1.57
Task-specific dystonias: a review. Ann N Y Acad Sci (2008) 1.54
Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases. Neurology (2013) 1.53
The value of quantitative electroencephalography in clinical psychiatry: a report by the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2006) 1.51
Cervical carotid and circle of willis arterial anatomy of macaque monkeys: a comparative anatomy study. Anat Rec (Hoboken) (2009) 1.47
Cueing the personal future to reduce discounting in intertemporal choice: Is episodic prospection necessary? Hippocampus (2015) 1.46
Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8. Mov Disord (2012) 1.44
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord (2008) 1.41
Are people really more patient than other animals? Evidence from human discounting of real liquid rewards. Psychon Bull Rev (2009) 1.41
Hippocampal volumes in youth with type 1 diabetes. Diabetes (2009) 1.38
Inhibitory control in children with autism spectrum disorder. J Autism Dev Disord (2007) 1.37
Relative risk of spread of symptoms among the focal onset primary dystonias. Mov Disord (2006) 1.36
Dissociable but inter-related systems of cognitive control and reward during decision making: evidence from pupillometry and event-related fMRI. Neuroimage (2007) 1.32
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons. J Neurosci (2011) 1.31
Dopamine modulates effort-based decision making in rats. Behav Neurosci (2009) 1.29
Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes (2011) 1.27
Amyloid imaging of Lewy body-associated disorders. Mov Disord (2010) 1.27
Predictors of survival in patients with Parkinson disease. Arch Neurol (2012) 1.27
Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Arch Neurol (2012) 1.26
Mapping Go-No-Go performance within the subthalamic nucleus region. Brain (2010) 1.26
Effect of stimulation frequency on tremor suppression in essential tremor. Mov Disord (2004) 1.26
A comparison of four models of delay discounting in humans. Behav Processes (2008) 1.26
Delay discounting of saccharin in rhesus monkeys. Behav Processes (2009) 1.25
Increased risk of parkinsonism associated with welding exposure. Neurotoxicology (2012) 1.23
A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci U S A (2002) 1.22
Domain independence and stability in young and older adults' discounting of delayed rewards. Behav Processes (2011) 1.22
Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiol Aging (2012) 1.22
Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17
Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology (2012) 1.17
Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care (2013) 1.17
Early brain vulnerability in Wolfram syndrome. PLoS One (2012) 1.17
White matter microstructural integrity in youth with type 1 diabetes. Diabetes (2012) 1.15
High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med Genet (2009) 1.14
Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. J Neurosci (2010) 1.12
[18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord (2005) 1.11
Greater loss of 5-HT(2A) receptors in midlife than in late life. Am J Psychiatry (2002) 1.11
On the scaling interpretation of exponents in hyperboloid models of delay and probability discounting. Behav Processes (2010) 1.09
Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome. Psychiatry Res (2007) 1.08
Suppression of cocaine self-administration in monkeys: effects of delayed punishment. Psychopharmacology (Berl) (2011) 1.07
A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse (2013) 1.07
Delay discounting of qualitatively different reinforcers in rats. J Exp Anal Behav (2010) 1.07
Gait and balance in essential tremor: variable effects of bilateral thalamic stimulation. Mov Disord (2009) 1.06
Dopaminergic modulation of response inhibition: an fMRI study. Brain Res Cogn Brain Res (2004) 1.06
Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth Analg (2006) 1.06
Discounting of Various types of rewards by women with and without binge eating Disorder: Evidence for general rather than specific Differences. Psychol Rec (2011) 1.05
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization. Synapse (2009) 1.05
Sustained neural activity associated with cognitive control during temporally extended decision making. Brain Res Cogn Brain Res (2005) 1.05
The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord (2011) 1.04
Podokinetic after-rotation in Parkinson disease. Brain Res (2006) 1.04
Prospective memory in Parkinson disease across laboratory and self-reported everyday performance. Neuropsychology (2009) 1.03
Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain. Bioorg Med Chem (2011) 1.03
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet (2007) 1.03
Modeling the effect of reward amount on probability discounting. J Exp Anal Behav (2011) 1.02
A kinematic and electromyographic analysis of turning in people with Parkinson disease. Neurorehabil Neural Repair (2008) 1.02
Short- and long-term spatial delayed response performance across the lifespan. Dev Neuropsychol (2004) 1.02
White matter integrity and executive abilities in individuals with phenylketonuria. Mol Genet Metab (2013) 1.02
Delay discounting in rhesus monkeys: equivalent discounting of more and less preferred sucrose concentrations. Learn Behav (2012) 1.02
Estimating the subjective value of future rewards: comparison of adjusting-amount and adjusting-delay procedures. Behav Processes (2012) 1.01
Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. Synapse (2012) 1.01
Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PLoS One (2013) 1.00
Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. J Neurosci Methods (2007) 0.99